FDA Approves OTC Version Of Heartburn Drug Zegerid
Merck and Santarus say FDA approves over-the-counter sales of Santarus heartburn drug Zegerid
07:12PM 12/01/09
The Amazing Shrinking Health Care Supply (RealMoney.com $)
As we close in on a resolution over reform, these names should continue to work higher.
12:34PM 11/27/09
Tracking the Hedgies (RealMoney Silver $)
Here is a summary of Goldman Sachs' Hedge Fund Trend Monitor this week.
08:08AM 11/23/09
FDA OKs Abilify For Autism-linked Irritability
FDA OKs Bristol-Meyers' Abilify to treat irritability linked to autism in children, teens
07:27PM 11/20/09
Moody's Gives Negative View On Pharma Credit
Moody's: credit ratings for drugmakers could be hurt as industry copes with expiring patents
01:15PM 11/19/09
InterMune Shares Fall On Change In Hepatitis Study
InterMune shares fall as it stops high dose of experimental drug in hepatitis C study
11:58AM 11/17/09
Financial ETFs for Playing M&A Wave
By Michael Johnston, Senior Contributor
Four ETFs offer a range of exposure to the giant investment banks.
12:24PM 11/16/09
Study Raises New Questions About Merck Pill Zetia
Niacin shrinks artery plaque; Merck's Zetia does not and may carry risks, new study finds
06:16PM 11/15/09
Sell Pfizer!: Against the Grain
WESTCHESTER COUNTY, NEW YORK -- Marek Fuchs tells traders not to leap two steps soon on Pfizer.
02:37PM 11/09/09
Doc Offers Top Hep C Drug Picks: BioBuzz
Vertex, InterMune, Pharmasset get positive reviews after recent Hep C meeting.
01:54PM 11/09/09
Pulte Homes, Merck, Garmin Are Big Movers
Pulte Homes, Merck, Garmin, Kraft, Ambac Financial are among big market movers Wednesday
04:36PM 11/04/09
Fitch Lowers Merck Ratings After Schering Purchase
With Merck acquisition of Schering-Plough complete, Fitch downgrades Merck; upgrades Schering
04:27PM 11/04/09
Merck, Now No. 2 Drugmaker, Set For Future Buys
Merck, now the world's No. 2 drugmaker with Schering-Plough purchase, set for future deals
08:38AM 11/04/09
Merck Completes $41B Purchase Of Schering-Plough
Merck is set to close $41B purchase of Schering-Plough, becoming world's No. 2 drugmaker
11:50AM 11/03/09



Connect with TheStreet